2024-03-012025-02-282025-02-28false04373372DAN MEDICA SOUTH LIMITED2025-11-26falseiso4217:GBPxbrli:pure043733722024-02-29043733722025-02-28043733722024-03-012025-02-28043733722023-02-28043733722024-02-29043733722023-03-012024-02-2904373372bus:SmallEntities2024-03-012025-02-2804373372bus:AuditExempt-NoAccountantsReport2024-03-012025-02-2804373372bus:FullAccounts2024-03-012025-02-2804373372bus:PrivateLimitedCompanyLtd2024-03-012025-02-2804373372core:WithinOneYear2025-02-2804373372core:AfterOneYear2025-02-2804373372core:WithinOneYear2024-02-2904373372core:AfterOneYear2024-02-2904373372core:ShareCapital2025-02-2804373372core:SharePremium2025-02-2804373372core:RevaluationReserve2025-02-2804373372core:OtherReservesSubtotal2025-02-2804373372core:RetainedEarningsAccumulatedLosses2025-02-2804373372core:ShareCapital2024-02-2904373372core:SharePremium2024-02-2904373372core:RevaluationReserve2024-02-2904373372core:OtherReservesSubtotal2024-02-2904373372core:RetainedEarningsAccumulatedLosses2024-02-2904373372core:LandBuildings2025-02-2804373372core:PlantMachinery2025-02-2804373372core:Vehicles2025-02-2804373372core:FurnitureFittings2025-02-2804373372core:OfficeEquipment2025-02-2804373372core:NetGoodwill2025-02-2804373372core:IntangibleAssetsOtherThanGoodwill2025-02-2804373372core:ListedExchangeTraded2025-02-2804373372core:UnlistedNon-exchangeTraded2025-02-2804373372core:LandBuildings2024-02-2904373372core:PlantMachinery2024-02-2904373372core:Vehicles2024-02-2904373372core:FurnitureFittings2024-02-2904373372core:OfficeEquipment2024-02-2904373372core:NetGoodwill2024-02-2904373372core:IntangibleAssetsOtherThanGoodwill2024-02-2904373372core:ListedExchangeTraded2024-02-2904373372core:UnlistedNon-exchangeTraded2024-02-2904373372core:LandBuildings2024-03-012025-02-2804373372core:PlantMachinery2024-03-012025-02-2804373372core:Vehicles2024-03-012025-02-2804373372core:FurnitureFittings2024-03-012025-02-2804373372core:OfficeEquipment2024-03-012025-02-2804373372core:NetGoodwill2024-03-012025-02-2804373372core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2804373372core:ListedExchangeTraded2024-03-012025-02-2804373372core:UnlistedNon-exchangeTraded2024-03-012025-02-2804373372core:MoreThanFiveYears2024-03-012025-02-2804373372core:Non-currentFinancialInstruments2025-02-2804373372core:Non-currentFinancialInstruments2024-02-2904373372dpl:CostSales2024-03-012025-02-2804373372dpl:DistributionCosts2024-03-012025-02-2804373372core:LandBuildings2024-03-012025-02-2804373372core:PlantMachinery2024-03-012025-02-2804373372core:Vehicles2024-03-012025-02-2804373372core:FurnitureFittings2024-03-012025-02-2804373372core:OfficeEquipment2024-03-012025-02-2804373372dpl:AdministrativeExpenses2024-03-012025-02-2804373372core:NetGoodwill2024-03-012025-02-2804373372core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2804373372dpl:GroupUndertakings2024-03-012025-02-2804373372dpl:ParticipatingInterests2024-03-012025-02-2804373372dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2804373372core:ListedExchangeTraded2024-03-012025-02-2804373372dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2804373372core:UnlistedNon-exchangeTraded2024-03-012025-02-2804373372dpl:CostSales2023-03-012024-02-2904373372dpl:DistributionCosts2023-03-012024-02-2904373372core:LandBuildings2023-03-012024-02-2904373372core:PlantMachinery2023-03-012024-02-2904373372core:Vehicles2023-03-012024-02-2904373372core:FurnitureFittings2023-03-012024-02-2904373372core:OfficeEquipment2023-03-012024-02-2904373372dpl:AdministrativeExpenses2023-03-012024-02-2904373372core:NetGoodwill2023-03-012024-02-2904373372core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2904373372dpl:GroupUndertakings2023-03-012024-02-2904373372dpl:ParticipatingInterests2023-03-012024-02-2904373372dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2904373372core:ListedExchangeTraded2023-03-012024-02-2904373372dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2904373372core:UnlistedNon-exchangeTraded2023-03-012024-02-2904373372core:NetGoodwill2025-02-2804373372core:IntangibleAssetsOtherThanGoodwill2025-02-2804373372core:LandBuildings2025-02-2804373372core:PlantMachinery2025-02-2804373372core:Vehicles2025-02-2804373372core:FurnitureFittings2025-02-2804373372core:OfficeEquipment2025-02-2804373372core:AfterOneYear2025-02-2804373372core:WithinOneYear2025-02-2804373372core:ListedExchangeTraded2025-02-2804373372core:UnlistedNon-exchangeTraded2025-02-2804373372core:ShareCapital2025-02-2804373372core:SharePremium2025-02-2804373372core:RevaluationReserve2025-02-2804373372core:OtherReservesSubtotal2025-02-2804373372core:RetainedEarningsAccumulatedLosses2025-02-2804373372core:NetGoodwill2024-02-2904373372core:IntangibleAssetsOtherThanGoodwill2024-02-2904373372core:LandBuildings2024-02-2904373372core:PlantMachinery2024-02-2904373372core:Vehicles2024-02-2904373372core:FurnitureFittings2024-02-2904373372core:OfficeEquipment2024-02-2904373372core:AfterOneYear2024-02-2904373372core:WithinOneYear2024-02-2904373372core:ListedExchangeTraded2024-02-2904373372core:UnlistedNon-exchangeTraded2024-02-2904373372core:ShareCapital2024-02-2904373372core:SharePremium2024-02-2904373372core:RevaluationReserve2024-02-2904373372core:OtherReservesSubtotal2024-02-2904373372core:RetainedEarningsAccumulatedLosses2024-02-2904373372core:NetGoodwill2023-02-2804373372core:IntangibleAssetsOtherThanGoodwill2023-02-2804373372core:LandBuildings2023-02-2804373372core:PlantMachinery2023-02-2804373372core:Vehicles2023-02-2804373372core:FurnitureFittings2023-02-2804373372core:OfficeEquipment2023-02-2804373372core:AfterOneYear2023-02-2804373372core:WithinOneYear2023-02-2804373372core:ListedExchangeTraded2023-02-2804373372core:UnlistedNon-exchangeTraded2023-02-2804373372core:ShareCapital2023-02-2804373372core:SharePremium2023-02-2804373372core:RevaluationReserve2023-02-2804373372core:OtherReservesSubtotal2023-02-2804373372core:RetainedEarningsAccumulatedLosses2023-02-2804373372core:AfterOneYear2024-03-012025-02-2804373372core:WithinOneYear2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:CostValuation2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2804373372core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2804373372core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2804373372core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2904373372core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2904373372core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2904373372bus:Director12024-03-012025-02-2804373372bus:Director22024-03-012025-02-28

DAN MEDICA SOUTH LIMITED

Registered Number
04373372
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2025

DAN MEDICA SOUTH LIMITED
Company Information
for the year from 1 March 2024 to 28 February 2025

Directors

Mr D Timm
Mrs L Timm

Registered Address

2 Upperton Gardens
Eastbourne
BN21 2AH

Registered Number

04373372 (England and Wales)
DAN MEDICA SOUTH LIMITED
Statement of Financial Position
28 February 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,3544,427
4,3544,427
Current assets
Stocks428,59071,767
Debtors521,51515,895
Cash at bank and on hand31,98436,113
82,089123,775
Creditors amounts falling due within one year6(29,022)(36,686)
Net current assets (liabilities)53,06787,089
Total assets less current liabilities57,42191,516
Provisions for liabilities7(827)(841)
Net assets56,59490,675
Capital and reserves
Called up share capital22
Profit and loss account56,59290,673
Shareholders' funds56,59490,675
The financial statements were approved and authorised for issue by the Board of Directors on 26 November 2025, and are signed on its behalf by:
Mrs L Timm
Director
Registered Company No. 04373372
DAN MEDICA SOUTH LIMITED
Notes to the Financial Statements
for the year ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with Financial Reporting standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions od Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in ta assessments in periods different fromthose in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Office Equipment25
Stocks and work in progress
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Government grants or assistance
Government grants are recognised under the accrual model with grants relating to revenue recognised in income on a systematic basis over the periods in which the entity recognised the related costs for which the grant is intended to compensate. A grant that becomes receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets shall be recognised in income on a systematic basis over the expected useful life of the asset.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 March 2413,32313,323
Additions1,2691,269
At 28 February 2514,59214,592
Depreciation and impairment
At 01 March 248,8968,896
Charge for year1,3421,342
At 28 February 2510,23810,238
Net book value
At 28 February 254,3544,354
At 29 February 244,4274,427
4.Stocks

2025

2024

££
Raw materials and consumables28,59071,767
Total28,59071,767
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables12,037-
Other debtors8,46014,970
Prepayments and accrued income1,018925
Total21,51515,895
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables3,3545,022
Taxation and social security17,47725,697
Other creditors8,1915,967
Total29,02236,686
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)827841
Total827841